English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/116637
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorJusticia, Carles-
dc.contributor.authorMartín, Abraham-
dc.contributor.authorRojas, Santiago-
dc.contributor.authorGironella, Meritxell-
dc.contributor.authorCervera, Álvaro-
dc.contributor.authorPanés, Julián-
dc.contributor.authorChamorro, Ángel-
dc.contributor.authorPlanas, Anna M.-
dc.identifierdoi: 10.1038/sj.jcbfm.9600198-
dc.identifierissn: 0271-678X-
dc.identifier.citationJournal of Cerebral Blood Flow and Metabolism 26(3): 421-432 (2006)-
dc.description.abstractCerebral ischemia triggers an inflammatory process involving the infiltration of leukocytes to the parenchyma. Circulating leukocytes adhere to the vascular wall through adhesion molecules. Here we quantified the in vivo expression of vascular cell adhesion molecule-1 (VCAM-1) in the brain, heart and lungs from 6 to 48 h after transient middle cerebral artery (MCA) occlusion in rats, by intravenous injection of a tracer radiolabelled anti-VCAM-1 antibody. The vascular localization of VCAM-1 was verified by immunohistochemistry after in vivo injection of the antibody. Vascular cell adhesion molecule-1 was strongly induced (4-fold at 24 h) in the microvasculature of the ischemic area, and, to a lesser extent, in the contralateral hemisphere and in a remote organ, the heart, but not in the lungs, indicating that the inflammatory process propagates beyond the injured brain. We injected intravenously either blocking doses of anti-VCAM-1 antibodies or control antibodies after MCA occlusion in rats and mice. We evaluated the neurological score in rats, and infarct volume at 2 days in rats and at 4 days in mice. Anti-VCAM-1 did not protect against ischemic damage either in rats or in mice. Vascular cell adhesion molecule-1 blockade significantly decreased the number of ED1 (labeling monocytes /macrophages/reactive microglia)-positive cells in the ischemic rat brain. However, it did not reduce the numbers of infiltrating neutrophils and lymphocytes, and total leukocytes (CD45 positive), which showed a trend to increase. The results show vascular upregulation of VCAM-1 after transient focal ischemia, but no benefits of blocking VCAM-1, suggesting that this is not a therapeutical strategy for stroke treatment. © 2006 ISCBFM All rights reserved.-
dc.description.sponsorshipThis work was supported by a grant from the Comisión Interministerial de Ciencia y Tecnologia (CICYT: SAF2002-01963) and the European Commission (CE QLG1-CT-2000-00562). CJ was partially supported by funds from the 'Red CIEN IDIBAPS-ISCIII RTIC, C03/06'-
dc.publisherLippincott Williams & Wilkins-
dc.subjectRemote organs-
dc.subjectMiddle cerebral artery occlusion-
dc.subjectAntibody treatment-
dc.subjectAdhesion molecules-
dc.titleAnti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice-
dc.description.versionPeer Reviewed-
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.